4 reports

Oncology and autoimmune diseases are still untouched by them due to which significant opportunities are left untapped.

  • Drug Delivery
  • Pharmaceutical
  • Transdermal Delivery
  • World
  • MARKET OVERVIEW
  • TECHNOLOGY PROVIDERS

NANOPASS LICENSED ITS MICRONJET NEEDLE TO CIRCASSIA, A UK BASED BIOPHARMACEUTICAL COMPANY FOCUSED ON DEVELOPING AND COMMERCIALISING DRUGS FOR ALLERGY AND AUTOIMMUNE DISEASES.

  • Transdermal Delivery
  • United States
  • Circassia Pharmaceuticals plc
  • Clearside Biomedical, Inc.
  • Zosano Pharma Corporation

It focuses on therapy areas such as respiratory cardiovascular and metabolic disease (CVMD)and cancer, besides autoimmune, infection and neurological diseases.

  • Clinical Trial
  • Transdermal Delivery
  • United States
  • Company
  • Aequus Pharmaceuticals Inc.

IT FOCUSES ON THERAPY AREAS SUCH AS RESPIRATORYCARDIOVASCULAR AND METABOLIC DISEASE (CVMD)AND CANCER, BESIDES AUTOIMMUNE, INFECTION AND NEUROLOGICAL DISEASES.

  • Transdermal Delivery
  • United States
  • Company
  • Company Financials
  • GlobalData's company